Abstract
The hospital mortality rate of patients with severe acute renal failure in patients requiring intensive care remains high. In order to compare patient groups in further trials concerning acute renal failure, recorded characteristics of the population should include age, previous health status, disease characteristics (initial or delayed acute renal failure, oliguria, sepsis), and the severity of the illness as assessed by physiologic scoring systems recorded at the time of study inclusion.
Keywords
Affiliated Institutions
Related Publications
Primary prevention of acute renal failure in the critically ill
The best evidence suggests that nonpharmacologic strategies are more effective than drugs in reducing the risk of acute renal failure. Evidence also exists that strategies that ...
Epidemiology and Outcomes of Acute Renal Failure in Hospitalized Patients
The aim of this study was to provide a broad characterization of the epidemiology of acute renal failure (ARF) in the United States using national administrative data and descri...
The pathogenesis of septic acute renal failure
This review suggests that, on the evidence available, septic acute renal failure is more likely to be an immune or toxic state rather than simply a hemodynamic condition. The au...
Hyperoncotic colloids and acute kidney injury: a meta-analysis of randomized trials
Abstract Introduction It has been hypothesized that hyperoncotic colloids might contribute to acute kidney injury (AKI). However, the validity of this hypothesis remains unclear...
Incidence and Outcomes in Acute Kidney Injury
Epidemiological studies of acute kidney injury (AKI) and acute-on-chronic renal failure (ACRF) are surprisingly sparse and confounded by differences in definition. Reported inci...
Publication Info
- Year
- 1996
- Type
- article
- Volume
- 24
- Issue
- 2
- Pages
- 192-198
- Citations
- 887
- Access
- Closed
External Links
Social Impact
Social media, news, blog, policy document mentions
Citation Metrics
Cite This
Identifiers
- DOI
- 10.1097/00003246-199602000-00003